About DoAI

OUR MISSION

Enabling human to live free life from diseasethrough the medical revolution based on AI technology.

OUR VISION

Realizing AI-based early diagnosis of cancer andpersonalized precision medical care.

2020

+ TIPS R&D Project selected

+ Korea Health Industry Development Institute project selected

+ Korea Credit Guarantee Fund <FIRST PENGUIN COMPANY> selected

+ $1.3M investment by Korea Credit Guarantee Fund

+ Korea Institute for Advancement of Technology <BIG3 Innovative Growth Support Project> selected

+ Korea Institute of Start-up and Entrepreneurship Development <Challenge! K-Startup 2020 AI League> advanced to the finals

2019

+ DoAI R&D Center accredited

+ Ministry of Health and Welfare & Asan Hospital chanllenge award : 2nd rank

+ Joint research project with SNUH

+ KOICA CTS project selected

+ Joint research contract signed with Asan Hospital

+ Joint research contract signed with GC Labs

+ Joint research project with CAU

+ $0.6M investment by GC Holdings

2018

+ DoAI Inc. founded

+ $1.8M investment by GC Holdings

+ MOU with University Medical Center (UMC) in Ho chi minh, Vietnam

+ Joint research contract signed with GC Genome : NIPT

Leadership

Michael Yong Choi / 최용준
Chief Executive Officer

    • + MBA, Stanford University
    • + BSE, Seoul National University
    • + Chairman’s office Strategic Planning, Tong Yang Group
    • + Chairman’s office Strategic Planning, LG group VisionTeam
    • + AT Kearney Management Consulting
    • + Arthur D. Little Management Consulting
    • + Founder of Onetel (Internet Phone)/ Onetrade
    • + Serial Entrepreneur & Company Building
    • + Fundamental Investment Group (Company Building)

Do Synho / 도신호
Scientific Advisor

    • + BA & ME, Electrical Engineering, Kyungpook National University
    • + PhD., Biomedical Engineering, University of Southern California
    • + Post Doctoral Training, Alfred E. Mann Institute, University of Southern California
    • + Post Doctoral Training, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital
    • + Assistant Professor, Radiology, Harvard Medical School
    • + Director, Laboratory of Medical Image and Computation
    • + Medical Director, Advanced Health Technology Engineering
    • + Research and Development, Massachusetts General Physicians Organization (MGPO)
    • + Adjunct professor, Samsung Advanced Institute of Health Sciences and Technology (SAIHST) and Samsung Medical Center

Moon Hanlim / 문한림
Chief Medical Officer, VP

    • + Ph.D., College of Medicine, Catholic University of Korea
    • + M.D & BS, College of Medicine, Catholic University of Korea
    • + CEO, CUREnCARE Research
    • + Consultant as CSO, Mdimune (Exosom-drug Development)
    • + Director of R&D Center, ADM Korea (Clinical CRO)
    • + Medical Director, Asia Pacific Pierre-Fabre Medicament
    • + Head of Medical Affairs, Mundipharma Pte Ltd
    • + President & CEO, OxOnc Development Asia LLC
    • + Consultant physician, Oxford Oncology
    • + Oncology Medical Director, GlaxoSmithKline

Jwa-Min Nam / 남좌민
Domain Chief Technology Officer

    • + BA & MS, Chemistry, Hanyang University
    • + PhD., Chemistry, Northwestern University
    • + Post Doctoral Fellow, Department of Chemistry, UC Berkeley & Lawrence Berkeley National Laboratory
    • + Professor, Department of Chemistry, Seoul National University
    • + Consultant, Nanosphere, Inc.
    • + Division Leader (Research Support Division), Bio-MAX/N-Bio, Seoul National University
    • + Department Head, Department of Education, National Center for Inter-University Research Facilities, Seoul National University
    • + Vice Chair/Division Leader (Division of Science), Young Korean Academy of Science and Technology
    • + Visiting Professor, Samsung Advanced Institute of Technology, UC Berkeley, National University of Singapore, Peking University, The University of Tokyo, Nanyang Technological University & Institute of Physics, Chinese Academy of Sciences
    • + Member, Samsung Electronics Future Technology Committee
    • + Vice Chair, Department of Chemistry, Seoul National University
    • + Associate Editor, Nano Letters (ACS Publications)

Lee Jungho / 이정호
Chief Operating Officer, VP

    • + PhD Candidate, Bioengineering, Yonsei University College of Medicine
    • + BS & MD, Medical Data Statistics, Yonsei University College of Medicine
    • + Vice Chair, Wellness IT Association, Ministry of Science ICT and Future Planning
    • + CEO, TPLUS

Advisors

Yoon Sungroh / 윤성로
Advisor

    • B.S., Electrical Engineering, Seoul National University
    • M.S., Electrical Engineering, Stanford University
    • PhD., Electrical Engineering, Stanford University
    • Vice Chair, Department of Electrical and Computer Engineering, Seoul National University
    • Associate Professor, Department of Electrical and Computer Engineering, Seoul National University
    • Assistant Professor, Department of Electrical Engineering, Korea University

Moon Youngwan / 문영완
Advisor

    • M.D. & B.S., College of Medicine, Seoul National University
    • M.S., College of Medicine, Catholic University
    • Ph.D., College of Medicine, Catholic University
    • Professor, Department of Orthopedic Surgery, Sungkyunkwan University, School of Medicine
    • Director, Center of Bone and Joint disease, Samsung Medical Center
    • Visiting Fellow, Department of Orthopedic Surgery, Massachusetts General Hospital (MGH)

Steve Chai / 채수일
Adviser

    • B.S., Electrical Engineering, University of Southern California
    • M.Sc., Electrical Engineering, University of Southern California
    • MBA, Management and Finance, Wharton School of the University of Pennsylvania
    • The Boston Consulting Group, Standing adviser
    • The Boston Consulting Group, CEO in Korea Region
    • The Boston Consulting Group, Management commissioner in Asia-Pacific Region
    • The Boston Consulting Group, Consultant Team Leader